SCHEMBL27485592

SCHEMBL27485592

Nc1c(F)ccc(C(=O)Nc2cccc(C(F)(F)F)c2)c1Cc1ccncc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 8/20 0.57
▸ FLT1 P17948 5/20 0.57
▸ ABL1 P00519 1/20 0.57
▸ EGFR P00533 1/20 0.57
▸ CSF1R P07333 1/20 0.57
▸ PDGFRB P09619 1/20 0.57
▸ KIT P10721 1/20 0.57
▸ FLT4 P35916 1/20 0.57
▸ GAA P10253 1/20 0.53
▸ AHR P35869 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ PTGS1 P23219 1/20 0.52
▸ LCK P06239 2/20 0.50
▸ TEK Q02763 1/20 0.50
▸ IDE P14735 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ MAPK10 P53779 1/20 0.49
▸ MEN1 O00255 1/20 0.47
▸ TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27466657 0.87 PTGS1 (0.64) KDRFLT1ABL1EGFRCSF1R
SCHEMBL27485593 0.85 KDR (0.56) KDRFLT1ABL1EGFRCSF1R
SCHEMBL4981385 0.82 KDR (0.68) KDRFLT1ABL1EGFRCSF1R
SCHEMBL27548630 0.80 PTGS1 (0.63) KDRFLT1ABL1EGFRCSF1R
SCHEMBL27484180 0.78 GRM4 (0.50) KDRFLT1ABL1EGFRCSF1R
SCHEMBL27467095 0.78 P2RX1 (0.54) KDRFLT1ABL1EGFRCSF1R
SCHEMBL5964888 0.76 KDR (0.60) KDRFLT1ABL1EGFRCSF1R
SCHEMBL27483851 0.76 PTGS1 (0.60) KDRFLT1ABL1EGFRCSF1R
SCHEMBL4979871 0.76 KDR (0.77) KDRFLT1ABL1EGFRCSF1R
SCHEMBL427738 0.74 KDR (0.68) KDRFLT1ABL1EGFRCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN claimed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback